Treating rheumatic disorders

Categories 43rd CongressTags , ,

Dr. med. Wolfgang Rohrer, Klosters, Switzerland SUMMARY Treating rheumatic disorders with the chemotherapeutic agents known to conventional medicine (methotrexate, leflunomide, etc.) frequently presents difficult problems for the patient as well as the physician. The potential side effects of these drugs, in particular, can be extremely unpleasant for the patient and create real problems for the…

This content is for Full membership and Free Trial members only.
Log In Register